MHMark Holland

Mark Holland

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mark Holland has a total of 95 co-authors. Here are the top co-authors by number of shared publications:

  • Tim Cooksley

    Department of Acute Medicine, The Christie NHS Foundation Trust, Manchester, UK

    8 shared publications
  • John Kellett

    School of Clinical and Biomedical Sciences, University of Greater Manchester , A676 Deane Rd, Bolton BL3 5AB, Manchester

    4 shared publications
  • Catherine Atkin

    Acute Care, College of Medicine and Health, University of Birmingham, Birmingham, BIRMINGHAM, UK

    3 shared publications
  • Daniel Lasserson

    Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry CV4 7AL, UK; Division of Acute General Medicine, Oxford University Hospitals NHS Foundation Trust, Headington, Oxford OX3 9DU, UK

    3 shared publications
  • Darren Green

    Salford Care Organisation, Northern Care Alliance NHS Foundation Trust, UK; University of Manchester, Manchester, UK

    3 shared publications
  • Thomas Knight

    Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, University of Birmingham, Edgbaston, Birmingham B15 2GW, UK

    3 shared publications

Latest Publications

  • Open Access

    Access, bedside assessment, faulty information, and not considering what matters to patients—four impediments to acute medical care that should be addressed

    by John Kellett, Mark Holland

    The growth of medical technology and subspecialization means that most medical care can no longer be provided by single doctors working alone. Notwithstanding its benefits, this transition of care from individuals to teams has made healthcare fragmented, with loss of continuity and potentially dangerous hand-overs, which can result in futile cycles of further enquiry before any effective intervention is delivered. These and other unforeseen consequences have, in our opinion, created major challenges for the care of acutely ill patients, which include reduced availability and slow access to acute care, and the impairment of the traditional bedside assessment and diagnostic processes due to faulty or missing information. To correct these issues, essential information, which harms patients if it is incorrect or unavailable, needs to be clearly defined, with systems put in place to ensure it is complete, current, correct, and immediately available. Furthermore, acute care would be focused more on patient needs if quality-of-care outcomes more explicitly measured what matters most to patients.

  • The variable relationship between the National Early Warning Score on admission to hospital, the primary discharge diagnosis, and in-hospital mortality

    by Mark Holland, John Kellett, Stelios Boulitsakis-Logothetis, Matthew Watson, Noura Al Moubayed, Darren Green

    Background Patients with an elevated admission National Early Warning Score (NEWS) are more likely to die while in hospital. However, it is not known if this increased mortality risk is the same for all diagnoses. The aim of this study was to determine and compare the increased risk of in-hospital mortality associated with an elevated NEWS and different primary discharge diagnoses in unselected emergency admissions to a UK university teaching hospital. Methods A non-interventional observational study of 122,321 consecutive, unselected, adult patients with complete data admitted as an emergency between 2014 and 2022. Results The overall in-hospital mortality was 4.3%. Eighty diagnostic groupings accounted for 85.8% of all admissions and 89.4% of all in-hospital deaths. Depending on diagnostic grouping, the risk of mortality associated with an admission NEWS ≥ 3 ranged from 2.3- to 100-fold. For example, the in-hospital mortality of COPD patients increased from 1.9% for those with admission NEWS < 3 to 35.6% for those with NEWS ≥ 3, for chest pain mortality increased from 0.1 to 3.9%, and for patients with an opiate overdose from 0.2 to 7.7%. Conversely, for admission NEWS < 3, aspiration pneumonia and intracranial hemorrhage had in-hospital mortalities of 13.7% and 12.1%, respectively. Discussion There is enormous variation in the mortality risk associated with an increased admission NEWS in different commonly encountered diagnoses. Therefore, the mortality risk of some ‘low risk’ conditions can be dramatically increased if their admission NEWS is elevated, whereas some ‘high risk’ conditions are still likely to die even if their admission NEWS is low.


  • Open Access

    Performance of machine learning versus the national early warning score for predicting patient deterioration risk: a single-site study of emergency admissions

    by Matthew Watson, Stelios Boulitsakis Logothetis, Darren Green, Mark Holland, Pinkie Chambers, Noura Al Moubayed

    Objectives: Increasing operational pressures on emergency departments (ED) make it imperative to quickly and accurately identify patients requiring urgent clinical intervention. The widespread adoption of electronic health records (EHR) makes rich feature patient data sets more readily available. These large data stores lend themselves to use in modern machine learning (ML) models. This paper investigates the use of transformer-based models to identify critical deterioration in unplanned ED admissions, using free-text fields, such as triage notes, and tabular data, including early warning scores (EWS). Design: A retrospective ML study. Setting: A large ED in a UK university teaching hospital. Methods: We extracted rich feature sets of routine clinical data from the EHR and systematically measured the performance of tree- and transformer-based models for predicting patient mortality or admission to critical care within 24 hours of presentation to ED. We compared our proposed models to the National EWS (NEWS). Results: Models were trained on 174 393 admission records. We found that models including free-text triage notes outperform structured tabular data models, achieving an average precision of 0.92, compared with 0.75 for tree-based models and 0.12 for NEWS. Conclusions: Our findings suggests that machine learning models using free-text data have the potential to improve clinical decision-making in the ED; our techniques significantly reduce alert rate while detecting most high-risk patients missed by NEWS.


  • Open Access

    Provision of medical Same Day Emergency Care services within the UK: analysis from the Society for Acute Medicine Benchmarking Audit

    by C Atkin, M Perrett, M Holland, T Cooksley, T Knight, R Varia, C Subbe, Ds Lasserson, E Sapey

    Aim To evaluate current provision of medical Same Day Emergency Care (SDEC) services within the UK, and current utilisation of these pathways in the assessment of unplanned medical attendances. Design Survey data was used from the Society for Acute Medicine Benchmarking Audit (SAMBA), including anonymised patient-level data collected annually using a day of care survey Setting Hospitals accepting unplanned medical attendances within the UK, 2019-2023. Participants: 34,948 unplanned and 4,342 planned attendances, across 188 hospital sites Results 29.8% of unplanned medical attendances received their initial medical assessment within SDEC services, with the proportion increasing over time. 82.4% of patients assessed in SDEC services were discharged without overnight admission. Assessment in SDEC services was less likely in male patients, patients with frailty, and older adults (all pConclusions Medical SDEC provides assessment for one third of patients seen through acute medicine services. Although the proportion of patients assessed within SDEC is increasing, further innovation and improvements are needed to ensure appropriate patients access this service. Strengths and limitations of this study -Medical same day emergency care (SDEC) has been widely adopted in the UK to deliver care to patients without overnight hospital admission, however there is limited evidence guiding development of this service. -This study compares hospital-level data describing SDEC service structure and processes, and patient level data for over 35,000 patient attendances at 188 hospitals in the UK. -This is the largest evaluation of medical SDEC to date and demonstrates an increase in the use of SDEC for medical patients nationally. -The participation rate was higher amongst hospitals in England compared to the other three UK nations, which may limit generalisability.


  • Open Access

    Evaluation of venous thromboembolism risk assessment models for hospital inpatients: the VTEAM evidence synthesis

    by Daniel Edward Horner, Sarah Davis, Abdullah Pandor, Helen Shulver, Steve Goodacre, Daniel Hind, Saleema Rex, Michael Gillett, Matthew Bursnall, Xavier Griffin, et al.

    Background: Pharmacological prophylaxis during hospital admission can reduce the risk of acquired blood clots (venous thromboembolism) but may cause complications, such as bleeding. Using a risk assessment model to predict the risk of blood clots could facilitate selection of patients for prophylaxis and optimise the balance of benefits, risks and costs. Objectives: We aimed to identify validated risk assessment models and estimate their prognostic accuracy, evaluate the cost-effectiveness of different strategies for selecting hospitalised patients for prophylaxis, assess the feasibility of using efficient research methods and estimate key parameters for future research. Design: We undertook a systematic review, decision-analytic modelling and observational cohort study conducted in accordance with Enhancing the QUAlity and Transparency Of health Research (EQUATOR) guidelines. Setting: NHS hospitals, with primary data collection at four sites. Participants: Medical and surgical hospital inpatients, excluding paediatric, critical care and pregnancy-related admissions. Interventions: Prophylaxis for all patients, none and according to selected risk assessment models. Main outcome measures: Model accuracy for predicting blood clots, lifetime costs and quality-adjusted life-years associated with alternative strategies, accuracy of efficient methods for identifying key outcomes and proportion of inpatients recommended prophylaxis using different models. Results: We identified 24 validated risk assessment models, but low-quality heterogeneous data suggested weak accuracy for prediction of blood clots and generally high risk of bias in all studies. Decision-analytic modelling showed that pharmacological prophylaxis for all eligible is generally more cost-effective than model-based strategies for both medical and surgical inpatients, when valuing a quality-adjusted life-year at £20,000. The findings were more sensitive to uncertainties in the surgical population; strategies using risk assessment models were more cost-effective if the model was assumed to have a very high sensitivity, or the long-term risks of post-thrombotic complications were lower. Efficient methods using routine data did not accurately identify blood clots or bleeding events and several pre-specified feasibility criteria were not met. Theoretical prophylaxis rates across an inpatient cohort based on existing risk assessment models ranged from 13% to 91%. Limitations: Existing studies may underestimate the accuracy of risk assessment models, leading to underestimation of their cost-effectiveness. The cost-effectiveness findings do not apply to patients with an increased risk of bleeding. Mechanical thromboprophylaxis options were excluded from the modelling. Primary data collection was predominately retrospective, risking case ascertainment bias. Conclusions: Thromboprophylaxis for all patients appears to be generally more cost-effective than using a risk assessment model, in hospitalised patients at low risk of bleeding. To be cost-effective, any risk assessment model would need to be highly sensitive. Current evidence on risk assessment models is at high risk of bias and our findings should be interpreted in this context. We were unable to demonstrate the feasibility of using efficient methods to accurately detect relevant outcomes for future research. Future work: Further research should evaluate routine prophylaxis strategies for all eligible hospitalised patients. Models that could accurately identify individuals at very low risk of blood clots (who could discontinue prophylaxis) warrant further evaluation. Study registration: This study is registered as PROSPERO CRD42020165778 and Researchregistry5216. Funding: This award was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme (NIHR award ref: NIHR127454) and will be published in full in Health Technology Assessment; Vol. 28, No. 20. See the NIHR Funding and Awards website for further award information.


  • Open Access

    Effectiveness and cost effectiveness of pharmacological thromboprophylaxis for medical inpatients: decision analysis modelling study

    by Sarah Davis, Steve Goodacre, Daniel Horner, Abdullah Pandor, Mark Holland, Kerstin de Wit, Beverley J Hunt, Xavier Luke Griffin

    Objective: To determine the balance of costs, risks, and benefits for different thromboprophylaxis strategies for medical patients during hospital admission. Design: Decision analysis modelling study. Setting: NHS hospitals in England. Population: Eligible adult medical inpatients, excluding patients in critical care and pregnant women. Interventions: Pharmacological thromboprophylaxis (low molecular weight heparin) for all medical inpatients, thromboprophylaxis for none, and thromboprophylaxis given to higher risk inpatients according to risk assessment models (Padua, Caprini, IMPROVE, Intermountain, Kucher, Geneva, and Rothberg) previously validated in medical cohorts. Main outcome measures: Lifetime costs and quality adjusted life years (QALYs). Costs were assessed from the perspective of the NHS and Personal Social Services in England. Other outcomes assessed were incidence and treatment of venous thromboembolism, major bleeds including intracranial haemorrhage, chronic thromboembolic complications, and overall survival. Results: Offering thromboprophylaxis to all medical inpatients had a high probability (>99%) of being the most cost effective strategy (at a threshold of £20 000 (€23 440; $25 270) per QALY) in the probabilistic sensitivity analysis, when applying performance data from the Padua risk assessment model, which was typical of that observed across several risk assessment models in a medical inpatient cohort. Thromboprophylaxis for all medical inpatients was estimated to result in 0.0552 additional QALYs (95% credible interval 0.0209 to 0.1111) while generating cost savings of £28.44 (−£47 to £105) compared with thromboprophylaxis for none. No other risk assessment model was more cost effective than thromboprophylaxis for all medical inpatients when assessed in deterministic analysis. Risk based thromboprophylaxis was found to have a high (76.6%) probability of being the most cost effective strategy only when assuming a risk assessment model with very high sensitivity is available (sensitivity 99.9% and specificity 23.7% v base case sensitivity 49.3% and specificity 73.0%). Conclusions: Offering pharmacological thromboprophylaxis to all eligible medical inpatients appears to be the most cost effective strategy. To be cost effective, any risk assessment model would need to have a very high sensitivity resulting in widespread thromboprophylaxis in all patients except those at the very lowest risk, who could potentially avoid prophylactic anticoagulation during their hospital stay.


  • Open Access

    Performance of admission pathways within acute medicine services: Analysis from the Society for Acute Medicine Benchmarking Audit 2022 and comparison with performance 2019 - 2021

    by Catherine Atkin, Thomas Knight, Tim Cooksley, Mark Holland, Chris Subbe, Adrian Kennedy, Ragit Varia, Adnan Gebril, Daniel Lasserson